JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

Search

NeoGenomics Inc

Gesloten

10.63 1.82

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

10.53

Max

10.69

Belangrijke statistieken

By Trading Economics

Inkomsten

-19M

-45M

Verkoop

13M

181M

Winstmarge

-24.867

Werknemers

2,200

EBITDA

-41M

-48M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+6.19% upside

Dividenden

By Dow Jones

Volgende Winsten

28 okt 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

537M

1.4B

Vorige openingsprijs

8.81

Vorige sluitingsprijs

10.63

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

NeoGenomics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 okt 2025, 16:25 UTC

Belangrijke Marktbewegers

Obook Shares Rise, Company Secures New Money Transmitter Licenses

23 okt 2025, 12:37 UTC

Belangrijke Marktbewegers
Acquisities, Fusies, Overnames

Solmate Infrastructure Shares Higher on Acquisition Plans

22 okt 2025, 16:54 UTC

Belangrijke Marktbewegers

Applied DNA Sciences Shares Rise After Private Investment, Crypto Buys

21 okt 2025, 13:09 UTC

Winsten
Belangrijke Marktbewegers

Galaxy Digital Shares Jump on Swing to 3Q Profit, Surging Revenue

17 okt 2025, 15:03 UTC

Belangrijke Marktbewegers

Obook Shares Sink Following Public Debut

24 okt 2025, 13:16 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

24 okt 2025, 13:16 UTC

Marktinformatie

Bitcoin Rises After U.S. Inflation Data Firms Rate Cut Bets -- Market Talk

24 okt 2025, 06:59 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

24 okt 2025, 06:59 UTC

Marktinformatie

Bitcoin Rises on Confirmation of Trump-Xi Meeting -- Market Talk

23 okt 2025, 07:04 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

23 okt 2025, 07:04 UTC

Marktinformatie

Bitcoin Edges Higher But U.S.-China Tensions Limit Recovery -- Market Talk

22 okt 2025, 14:05 UTC

Marktinformatie

Bitcoin Could Briefly Fall Below $100K -- Market Talk

22 okt 2025, 09:30 UTC

Acquisities, Fusies, Overnames

Combination of FalconX, 21Shares to Develop Derivatives, Structured Products -- WSJ

22 okt 2025, 09:30 UTC

Acquisities, Fusies, Overnames

Crypto Trading Firm FalconX to Buy ETF Manager 21Shares -- WSJ

22 okt 2025, 09:30 UTC

Acquisities, Fusies, Overnames

FalconX to Fund 21Shares Deal Using Cash, Stock -- WSJ

22 okt 2025, 09:30 UTC

Acquisities, Fusies, Overnames

FalconX Strikes Deal to Buy Crypto Asset Manager 21Shares -- WSJ

22 okt 2025, 07:57 UTC

Marktinformatie

Bitcoin Falls After Confusing U.S.-China Signals -- Market Talk

21 okt 2025, 10:00 UTC

Acquisities, Fusies, Overnames

Deal Set to Come Later Tuesday, Executives Say -- WSJ

21 okt 2025, 10:00 UTC

Acquisities, Fusies, Overnames

Coinbase Strikes Deal for Crypto-Investing Platform Echo -- WSJ

21 okt 2025, 10:00 UTC

Acquisities, Fusies, Overnames

Coinbase Strikes Roughly $375M Deal for Crypto-Investing Platform Echo, Executives Say -- WSJ

21 okt 2025, 10:00 UTC

Acquisities, Fusies, Overnames

Coinbase to Fund Deal Using Cash and Stock, Executives Say -- WSJ

21 okt 2025, 08:00 UTC

Marktinformatie

Bitcoin Falls as Recovery Attempts Prove Short-Lived -- Market Talk

20 okt 2025, 14:30 UTC

Acquisities, Fusies, Overnames

Evernorth to Raise Over $1B in SPAC Deal with Armada II

20 okt 2025, 07:03 UTC

Marktinformatie

Bitcoin Rises on Hopes For De-Escalation in U.S.-China Tensions -- Market Talk

17 okt 2025, 10:37 UTC

Marktinformatie

Bitcoin Extends Losses as Investors Shun Risky Assets -- Market Talk

17 okt 2025, 07:08 UTC

Marktinformatie

Bitcoin Falls as U.S. Regional Bank Concerns, U.S.-China Tensions Weigh -- Market Talk

16 okt 2025, 19:37 UTC

Acquisities, Fusies, Overnames

Crypto Industry Dives Deeper Into Prediction Markets as Kraken Buys Exchange -- Barrons.com

16 okt 2025, 18:31 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

16 okt 2025, 18:31 UTC

Marktinformatie

Global Equities Roundup: Market Talk

16 okt 2025, 18:31 UTC

Marktinformatie

Charles Schwab Readies Spot Crypto Trading -- Market Talk

Peer Vergelijking

Prijswijziging

NeoGenomics Inc Prognose

Koersdoel

By TipRanks

6.19% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 11.33 USD  6.19%

Hoogste 14 USD

Laagste 8 USD

Gebaseerd op 10 Wall Street-analisten die 12-maands prijsdoelen bieden voor NeoGenomics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

10 ratings

5

Buy

5

Hold

0

Sell

Technische score

By Trading Central

7.7 / 10.27Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

Bearish Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
help-icon Live chat